Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine (KCONVAC) in Healthy Adults: Two Randomized, Double-blind, and Placebo-controlled Phase 1/2 Clinical Trials
Hongxing Pan, Jiankai Liu, Baoying Huang, Guifan Li, Xianyun Chang, Yafei Liu, Wenling Wang, Kai Chu, Jialei Hu, Jingxin Li, Dandan Zhu, Jingliang Wu, Xiaoyu Xu, Li Zhang, Meng Wang, Wenjie Tan, Weijin Huang, Fengcai Zhu
doi: https://doi.org/10.1101/2021.04.07.21253850
Hongxing Pan
1NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China or at
Jiankai Liu
Baoying Huang
Guifan Li
Xianyun Chang
Yafei Liu
Wenling Wang
Kai Chu
Jialei Hu
Jingxin Li
Dandan Zhu
Jingliang Wu
Xiaoyu Xu
Li Zhang
Meng Wang
Wenjie Tan
1NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China or at
Weijin Huang
2China National Institute for Food and Drug Control, Beijing, 102206, China or at
Fengcai Zhu
3Jiangsu Provincial Center of Disease Control and Prevention, Nanjing 210009, China or at
Data Availability
Supporting clinical documents including study protocol and statistical analysis plan will be available immediately following publication for at least 1 year. Researchers who provide a scientifically sound proposal will be allowed access to the individual participant data. Proposals should be directed to jszfc{at}vip.sina.com. These proposals will be reviewed and approved by the funder, investigator, and collaborators on the basis of scientific merit. To gain access, data requesters will need to sign a data access agreement.
Posted April 08, 2021.
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine (KCONVAC) in Healthy Adults: Two Randomized, Double-blind, and Placebo-controlled Phase 1/2 Clinical Trials
Hongxing Pan, Jiankai Liu, Baoying Huang, Guifan Li, Xianyun Chang, Yafei Liu, Wenling Wang, Kai Chu, Jialei Hu, Jingxin Li, Dandan Zhu, Jingliang Wu, Xiaoyu Xu, Li Zhang, Meng Wang, Wenjie Tan, Weijin Huang, Fengcai Zhu
medRxiv 2021.04.07.21253850; doi: https://doi.org/10.1101/2021.04.07.21253850
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine (KCONVAC) in Healthy Adults: Two Randomized, Double-blind, and Placebo-controlled Phase 1/2 Clinical Trials
Hongxing Pan, Jiankai Liu, Baoying Huang, Guifan Li, Xianyun Chang, Yafei Liu, Wenling Wang, Kai Chu, Jialei Hu, Jingxin Li, Dandan Zhu, Jingliang Wu, Xiaoyu Xu, Li Zhang, Meng Wang, Wenjie Tan, Weijin Huang, Fengcai Zhu
medRxiv 2021.04.07.21253850; doi: https://doi.org/10.1101/2021.04.07.21253850
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (683)
- Anesthesia (183)
- Cardiovascular Medicine (2722)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12370)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4223)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2725)
- Health Policy (1013)
- Hematology (369)
- HIV/AIDS (873)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4001)
- Nursing (216)
- Nutrition (592)
- Oncology (2110)
- Ophthalmology (602)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1143)
- Primary Care Research (465)
- Public and Global Health (6626)
- Radiology and Imaging (1439)
- Respiratory Medicine (882)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (460)
- Toxicology (57)
- Transplantation (192)
- Urology (171)